Clinical Implication of 18F-FDG-PET in Diagnosing and Monitoring Disease Activity in a Case of Subclinical Stage of Giant Cell Arteritis.
10.4078/jrd.2015.22.6.382
- Author:
Su Jin YOO
1
;
Jeong Chan LEE
;
Young KIM
;
In Seol YOO
;
Seung Cheol SHIM
;
Kun Ho KIM
;
Seong Wook KANG
Author Information
1. Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea. kangsw@cnuh.co.kr
- Publication Type:Case Report
- Keywords:
Giant cell arteritis;
Polymyalgia rheumatica;
Positron emission tomography
- MeSH:
Aged;
Biopsy;
Diagnosis;
Giant Cell Arteritis*;
Giant Cells*;
Humans;
Male;
Polymyalgia Rheumatica;
Positron-Emission Tomography;
Systemic Vasculitis;
Temporal Arteries;
Vasculitis
- From:Journal of Rheumatic Diseases
2015;22(6):382-386
- CountryRepublic of Korea
- Language:English
-
Abstract:
Giant cell arteritis (GCA) is a systemic vasculitis which typically occurs in persons over 50 years old. GCA is closely related to polymyalgia rheumatica (PMR). A temporal artery biopsy is the gold standard test for the diagnosis of GCA. Recently, there is increasing evidence for the role of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in diagnosis of vasculitis. Here, we report on a case of a 67-year-old Korean male who was diagnosed with atypical GCA in subclinical stage concomitant with PMR by 18F-FDG-PET. After treatment, abnormal findings of 18F-FDG-PET were improved.
